249 related articles for article (PubMed ID: 32581996)
1. The Clinical Value of
Liu X; Shan W; Zhao X; Ren J; Ren G; Chen C; Shi W; Lv R; Li Z; Liu Y; Ai L; Wang Q
Front Neurol; 2020; 11():418. PubMed ID: 32581996
[No Abstract] [Full Text] [Related]
2. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
[TBL] [Abstract][Full Text] [Related]
3. Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Zhao X; Zhao S; Chen Y; Zhang Z; Li X; Liu X; Lv R; Wang Q; Ai L
Front Immunol; 2021; 12():672846. PubMed ID: 34616389
[TBL] [Abstract][Full Text] [Related]
4. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.
Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ
CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554
[TBL] [Abstract][Full Text] [Related]
5. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
Sadaghiani MS; Roman S; Diaz-Arias LA; Habis R; Venkatesan A; Probasco JC; Solnes LB
Neuroradiology; 2023 Aug; 65(8):1225-1238. PubMed ID: 37264220
[TBL] [Abstract][Full Text] [Related]
6. Brain Metabolic Alterations in Seropositive Autoimmune Encephalitis: An
Bergeret S; Birzu C; Meneret P; Giron A; Demeret S; Marois C; Cousyn L; Rozenblum L; Laurenge A; Alentorn A; Navarro V; Psimaras D; Kas A
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831042
[TBL] [Abstract][Full Text] [Related]
7. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
[TBL] [Abstract][Full Text] [Related]
8. Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.
Rissanen E; Carter K; Cicero S; Ficke J; Kijewski M; Park MA; Kijewski J; Stern E; Chitnis T; Silbersweig D; Weiner HL; Kim CK; Lyons J; Klein JP; Bhattacharyya S; Singhal T
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35091466
[TBL] [Abstract][Full Text] [Related]
9. Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report.
Cornacchini S; Farina A; Contento M; Berti V; Biggi M; Barilaro A; Massacesi L; Damato V; Rosati E
Front Neurol; 2022; 13():949240. PubMed ID: 36051221
[TBL] [Abstract][Full Text] [Related]
10. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
11. Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on
Wang K; Zhao X; Yuan L; Chen Q; Wang Q; Ai L
Front Neurol; 2023; 14():1100760. PubMed ID: 37064193
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.
Liu L; Lyu Z; Li H; Bai L; Wan Y; Li P
BMC Med Imaging; 2023 Nov; 23(1):193. PubMed ID: 37986052
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
14. Brain Magnetic Resonance Imaging Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis and Their Clinical Relevance: A Single-Center Study in China.
Shao X; Fan S; Luo H; Wong TY; Zhang W; Guan H; Qiu A
Front Neurol; 2020; 11():618109. PubMed ID: 33510707
[No Abstract] [Full Text] [Related]
15. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures.
Flanagan EP; Kotsenas AL; Britton JW; McKeon A; Watson RE; Klein CJ; Boeve BF; Lowe V; Ahlskog JE; Shin C; Boes CJ; Crum BA; Laughlin RS; Pittock SJ
Neurol Neuroimmunol Neuroinflamm; 2015 Dec; 2(6):e161. PubMed ID: 26468474
[TBL] [Abstract][Full Text] [Related]
16. Quantitative brain
Roman SN; Sadaghiani MS; Diaz-Arias LA; Le Marechal M; Venkatesan A; Solnes LB; Probasco JC
Ann Clin Transl Neurol; 2024 May; 11(5):1211-1223. PubMed ID: 38453690
[TBL] [Abstract][Full Text] [Related]
17. LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis.
Jang Y; Lee ST; Bae JY; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Irani SR; Chu K; Lee SK
J Neuroinflammation; 2018 Sep; 15(1):279. PubMed ID: 30253786
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET in Autoimmune Encephalitis: Utility, Pattern of Abnormalities, and Correlation with Autoantibodies.
Jha S; Nagaraj C; Mundlamuri RC; Alladi S; Nashi S; Kenchaiah R; Mahadevan A; Bhat M; Saini J; Netravathi M
Ann Indian Acad Neurol; 2022; 25(6):1122-1129. PubMed ID: 36911487
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
20. Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Wang J; Ge J; Jin L; Deng B; Tang W; Yu H; Zhang X; Liu X; Xue L; Zuo C; Chen X
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2394-2408. PubMed ID: 36929211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
